Advertisement

Ads Placeholder
Loading...

Polyphor AG

POLN.SWSIX
Healthcare
Biotechnology
CHF1.67
CHF-0.12(-6.91%)
Swiss Market is Open • 10:07

Polyphor AG Fundamental Analysis

Polyphor AG (POLN.SW) shows weak financial fundamentals with a PE ratio of -0.41, profit margin of -3.17%, and ROE of -1.32%. The company generates N/A in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

PEG Ratio-0.00
Current Ratio2.03

Areas of Concern

ROE-1.32%
Operating Margin-3.13%
We analyze POLN.SW's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -440.0/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-440.0/100

We analyze POLN.SW's fundamental strength across five key dimensions:

Efficiency Score

Weak

POLN.SW struggles to generate sufficient returns from assets.

ROA > 10%
-96.73%

Valuation Score

Excellent

POLN.SW trades at attractive valuation levels.

PE < 25
-0.41
PEG Ratio < 2
-0.00

Growth Score

Weak

POLN.SW faces weak or negative growth trends.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Excellent

POLN.SW maintains a strong and stable balance sheet.

Debt/Equity < 1
0.67
Current Ratio > 1
2.03

Profitability Score

Weak

POLN.SW struggles to sustain strong margins.

ROE > 15%
-131.90%
Net Margin ≥ 15%
-3.17%
Positive Free Cash Flow
N/A

Key Financial Metrics

Is POLN.SW Expensive or Cheap?

P/E Ratio

POLN.SW trades at -0.41 times earnings. This suggests potential undervaluation.

-0.41

PEG Ratio

When adjusting for growth, POLN.SW's PEG of -0.00 indicates potential undervaluation.

-0.00

Price to Book

The market values Polyphor AG at 1.38 times its book value. This may indicate undervaluation.

1.38

EV/EBITDA

Enterprise value stands at -0.59 times EBITDA. This is generally considered low.

-0.59

How Well Does POLN.SW Make Money?

Net Profit Margin

For every $100 in sales, Polyphor AG keeps $-3.17 as profit after all expenses.

-3.17%

Operating Margin

Core operations generate -3.13 in profit for every $100 in revenue, before interest and taxes.

-3.13%

ROE

Management delivers $-1.32 in profit for every $100 of shareholder equity.

-1.32%

ROA

Polyphor AG generates $-96.73 in profit for every $100 in assets, demonstrating efficient asset deployment.

-96.73%

Following the Money - Real Cash Generation

FCF Per Share

Each share generates $-3.82 in free cash annually.

$-3.82

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-0.41

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.00

vs 25 benchmark

P/B Ratio

Price to book value ratio

1.38

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.00

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.67

vs 25 benchmark

Current Ratio

Current assets to current liabilities

2.03

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-1.32

vs 25 benchmark

ROA

Return on assets percentage

-0.97

vs 25 benchmark

ROCE

Return on capital employed

-1.57

vs 25 benchmark

How POLN.SW Stacks Against Its Sector Peers

MetricPOLN.SW ValueSector AveragePerformance
P/E Ratio-0.4128.31 Better (Cheaper)
ROE-131.90%699.00% Weak
Net Margin-316.88%-130884.00% (disorted) Weak
Debt/Equity0.670.34 Weak (High Leverage)
Current Ratio2.032775.16 Strong Liquidity
ROA-96.73%-14469.00% (disorted) Weak

POLN.SW outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Polyphor AG's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ